Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cullinan Therapeutics Inc.

Clinical trials sponsored by Cullinan Therapeutics Inc., explained in plain language.

Cullinan Therapeutics Inc. CGEM NASDAQ

A clinical-stage biopharmaceutical company developing targeted cancer therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Not yet recruiting 2 Not yet finished but already full! 3 Terminated 1

Experimental cancer combo trial ends early

Disease control Terminated

This early-stage study tested a new drug called CLN-617, alone or with the immunotherapy Keytruda, in 23 adults with advanced solid tumors that had not responded to standard treatments. The goal was to check safety and find the right dose. However, the trial was terminated, so fu…

Phase: PHASE1 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC